Lipoprotein (a) levels in African-Americans with NIDDM

Diabetes Care

Volumn 19, Issue 10, 1996, Pages 1129-1134

  Scheer, W Douglas ^a   Boudreau, Donald A ^a   Cook, Curtiss B ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPOPROTEIN A; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; HUMAN; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0029827931     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.10.1129     Document Type: Article

References (36)

1. Tull ES, Roseman JM: Diabetes in African Americans. In Diabetes in America. 2nd ed. National Diabetes Data Group. Washington, DC, U.S. Govt. Printing Office, 1995, p. 613-630 (NIH publ. #95-1468)
2. Arauz C, Lackner C, Ramirez LC: Lipoprotein (a) levels in diabetic patients and its correlation with the metabolic control (Abstract). Diabetes 39:64A, 1990
3. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P: Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 117:42-47, 1992
4. Wolffenbuttel HR, Leurs PB, Sels JPJE, Rondas-Colbers GJWM, Menheere PPCA, Nieuwenhuijzen Kruseman AC: Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels. Diabet Med 10:427-430, 1993
5. Heesen BJ, Wolffenbuttel BHR, Leurs PB, Sels JPJE, Menheere PPCA, Jackle-Beckers SEC, Nieuwenhuijzen Kruseman AC: Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin dependent diabetes. Eur J Clin Invest 23:580-584, 1993
6. O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA: Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. Mayo Clin Proc 69:430-435, 1994
7. Ruiz J, Thillet J, Huby T, James RW, Erlich D, Flandre P, Froguel P, Chapman J, Passa PH: Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients: relationship with apolipoprotein(a) phenotypes. Diabetologia 37:585-591, 1994
8. Martinez-Triguero ML, Salvador A, Samper JM, Almela M, Vega L, Mora A, Martinez-Diago V: Lipoprotein (a) and other risk factors in patients with noninsulin-dependent diabetes mellitus. Coron Artery Dis 5:755-760, 1994
9. Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimotto T, Ohashi Y, Murase T: Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 18:241-244, 1995
10. Watts GF, Gwilym RM, Mazurkiewicz J, Coltart J: Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM. Diabetes Care 18:234-236, 1995
11. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E, Hillis LD, Hobbs HH: No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 15:850-855, 1995
12. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS: Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children: Bogalusa Heart Study. Circulation 84:160-167, 1991
13. Roseman JM: Diabetes in black Americans. In Diabetes in America: Diabetes Data Compiled. Harris MI, Hamman RF, Eds. National Diabetes Data Group. Washington, DC, U.S. Govt. Printing Office, 1984, p. 1-24. (DHHS publ. #85-1468)
14. Kumanyika S: Obesity in black women. Epidemiol Rev 9:31-50, 1998
15. Lackner C, Cohen JC, Hobbs HH: Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum Mol Genet 2:933-940, 1993
16. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ: Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein (a) alleles between American blacks and whites. Biochem Biophys Res Commun 191:1192-1196, 1993
17. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH: Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field electrophoresis. J Clin Invest 87:2077-2086, 1991
18. Kamboh MI, Ferrell RE, Kottke BA: Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 49:1063-1074, 1991
19. Howard BV, Ngoc-Anh L, Belcher JD, Flack JM, Jacobs DR, Lewis CE, Marcovina SM, Perkins LL: Concentrations of Lp(a) in black and white young adults: relationship to risk factors for cardiovascular disease. Ann Epidemiol 4:341-350, 1994
20. Marcovina SM, Albers JJ, Jacobs DR, Perkins LL, Lewis CE, Howard BV, Savage P: Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in Caucasians and African-Americans: the CARDIA study. Arterioscler Thromb 13:1037-1045, 1993
21. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP: Effects of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 41:246-255, 1995
22. Sandkamp M, Assman G: Lipoprotein (a) in PROCAM participants and young myocardial infarction survivors. In Lipoprotein (a). Scanu AM, Ed. San Diego, CA, Academic Press, 1990, p. 205-208
23. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PWF, Castelli WP, Schafer EJ: Effects of age, sex and menopausal status on plasma lipoprotein (a) levels: the Framingham offspring study. Circulation 87:1135-1141, 1993
24. Heller FR, Jamart J, Honore P, Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC, Buysschaert M: Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16:819-823, 1993
25. Sutherland W, Lewis-Barned NJ, Pratt MC, Tillman HC, Walker RJ: The response of plasma lipoprotein(a) concentration to acute hyperinsulinemia in patients with non-insulin dependent diabetes and in healthy subjects. Res Comm Chem Pathol Pharmacol 83:77-86, 1994
26. Haffner SM, Tuttle KR, Rainwater DL: Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 41:116-120, 1992
27. Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S: A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes. J Intern Med 236:305-313, 1994
28. McConathy WJ, Trieu VN, Koren E, Wang CS, Corder CC: Triglyceride-rich lipoprotein interactions with Lp(a). Chem Phys Lipids 67/68:105-113, 1994
29. Bartens W, Rader DJ, Talley G, Brewer HB Jr: Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Atherosclerosis 108:149-157, 1994
30. Bartens W, Rader DJ, Talley G, Brewer HB Jr: Lipoprotein (a) in patients with hyperlipidemia. Eur J Clin Invest 25:647-653, 1995
31. Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY: Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Diabetes Care 18:1191-1194, 1995
32. Kuusi T, Yki-Jarvinen H, Kauppinen-Makelin R, Jauhiainen M, Ehnholm C, Kauppila M, Seppala R Viikari J, Kujansuu E, Rajala S, Lahti J, Niskanen L, Marjanen T, Salo S, Ryysy L, Tulokas T, Taskinen MR: Effect of insulin treatment on serum lipoprotein (a) in non-insulin-dependent diabetes. Eur J Clin Invest 25:194-200, 1995
33. Csaszar A, Dieplinger H, Sandh olzer C, Karadi I, Juhasz E, Drexel H, Halmos T, Romics L, Patsch JR, Utermann G: Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 36:47-51, 1993
34. Haffner SM, Morales PA, Stern MP, Gruber MK: Lp(a) concentration in NIDDM. Diabetes 41:1267-1272, 1992
35. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM: Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 43:942-946, 1994
36. Joven J, Vilella E: Serum levels of lipoprotein (a) in patients with well-controlled non-insulin-dependent diabetes mellitus (Letter). J Am Med Assoc 265:1113-1114, 1991